Biotech Values

[Bio_pete]

SLNO - I took a position in SLNO earlier in the year & booked a 150% gain when the Data Safety Monitoring Board recommended to continue the trial. One of my luckiest trades since the stock gave back most of those gains at the End of the Day. I re-entered the stock & wouldn't be surprised to see a 100% gain when they announce completion of trial enrollment.

DCCR has a good safety history & the slow release formulation should reduce side effects. The numbers are small but Slide 12 of their investor presentation seems to indicate a positive drug effect. The Phase III has a low bar since they only need to show a reduced incidence of hyperphagia & the stock should skyrocket. I like the risk vs reward & I'm working with free money so I'm riding some shares to the end.

http://investors.soleno.life/static-files/1868bef5-4609-4435-8df4-e9a927f2f1dd